表紙
市場調查報告書
商品編碼
1067150

多工化驗的全球市場-市場規模,佔有率,產業趨勢:各產品,各類型,各終端用戶,各應用領域(研究開發,臨床診斷,其他),各地區-展望及預測(2021年∼2027年)

Global Multiplex Assay Market Size, Share & Industry Trends Analysis Report By Product, By Type, By End user, By Application (Research & Development, Clinical Diagnostics & Others), By Regional Outlook and Forecast, 2021 - 2027

出版日期: | 出版商: KBV Research | 英文 269 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球多工化驗的市場規模在預測期間內預計將以9.8%的年複合成長率增長,到2027年將達到40億美元。

市場促進成長因素有在伴隨診斷中擴大使用多重檢測,以及相對於單一檢測和傳統檢測的優勢。然而,高昂的設備成本、嚴格的法規和標準正在抑制市場增長。

本報告提供全球多工化驗市場的相關調查,提供市場概要,市場分析,企業簡介等全面性資訊。

目錄

第1章 市場範圍與調查手法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 競爭分析-世界

  • KBV基數矩陣
  • 最近的產業整體策略性開發
  • 頂級制勝策略

第4章 全球多工化驗市場:各產品

  • 全球試劑及消耗品市場:各地區
  • 全球設備及配件市場:各地區
  • 全球軟體和服務市場:各地區

第5章 全球多工化驗市場:各類型

  • 全球蛋白質為基礎的多工化驗市場:各地區
  • 全球核酸為基礎的多工化驗市場:各地區
  • 全球其他的市場:各地區

第6章 全球多工化驗市場:各終端用戶

  • 全球製藥及生物科技企業市場:各地區
  • 全球調查市場:各地區
  • 全球臨床實驗室市場:各地區
  • 全球醫院市場:各地區

第7章 全球多工化驗市場:各應用領域

  • 全球研究開發市場:各地區
  • 全球臨床診斷市場:各地區
  • 全球伴隨式診斷市場:各地區

第8章 全球多工化驗市場:各地區

  • 北美的多工化驗市場
  • 歐洲的多工化驗市場
  • 亞太地區的多工化驗市場
  • 南美·中東·非洲的多工化驗市場

第9章 企業簡介

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad laboratories, Inc.
  • Becton, Dickinson and Company
  • Seegene, Inc.
  • Randox Laboratories Limited
  • Illumina, Inc.
  • Qiagen N.V.
  • DiaSorin S.p.A.(Luminex Corporation)
  • Abcam plc
  • Meso Scale Diagnostics LLC
目錄

The Global Multiplex Assay Market size is expected to reach $4 billion by 2027, rising at a market growth of 9.8% CAGR during the forecast period.

A multiplex assay is a process that detects and quantifies many analytes such as biomolecules, proteins, cytokines, growth factors, and chemokines at the same time. In comparison to traditional approaches like ELISA, this assay is used to amplify many objectives in a polymerase chain reaction (PCR) and capture more details from minute amounts of proteins or other analytes in less time. Pathogen identification, RNA detection, gene detection analysis, linkage analysis, mutation analysis, and forensic studies all use multiplex assays.

Running numerous tests means there may be little differences within every run, which could affect the results. Running a single experiment prevents this fluctuation from having a large impact, thus any differences in the protein found to be more likely to indicate genuine relative abundance within the sample. One such disease is sepsis, which is defined by a shift in the levels of pro-inflammatory cytokines.

Certain chemicals, some of which have been explored as possible medicinal medications, can also alter cytokine levels. As a result, having a system that can assess the levels of many cytokines at the same time is advantageous. Each bead had captured antibodies for the above cytokines and was differentiated by the ratio of dye added in a bead-based approach.

In addition, high-throughput multiplex detection techniques are used to evaluate a large number of analytes such as nucleic acid assays, immunoassays, enzyme assays, or receptor ligands, in a single biological sample in a fast, sensitive, and specific manner. These methods allow the analysis of a huge number of samples in one go.

COVID-19 impact Analysis

The COVID-19 pandemic has wreaked havoc on healthcare workflows all around the world. Numerous industries, including plenty of sub-domains of health care, have been compelled to temporarily shut down their production facilities because of the disease. Since multiplex assays are used to diagnose coronaviruses, there has been a substantial demand for multiplex SARS-CoV-2 assays, such as multiplex point-of-care assays, which have helped the multiplex assay market grow during the pandemic. The link of COVID-19 with multiple hazardous disorders increased the utilization of multiplex assays across the market.

In addition, to address the growing demand of the high volume of testing, several businesses got FDA emergency use authorization for their COVID-19 multiplex assays. However, the companies had to deal with several operational issues that hindered their commercial operations throughout the lockdown.

Market Growth Factors:

Increasing popularity of companion diagnostics

Companion diagnostics method is rapidly emerging and being utilized in therapeutics. A companion diagnostic is a diagnostic test that is used in conjunction with a therapeutic drug to determine whether the specific personalized medicine is appropriate for a particular person. Companion diagnostics assays can be conducted on a tissue biopsy or a blood sample utilizing various genomic or protein-based technologies such as next Generation Sequencing, qPCR, and Immunohistochemistry. In the case of cancer, a companion diagnostic test can determine whether a patient's tumor has a specific genetic aberration, such as a mutation, or changed protein expression, that predicts better therapeutic medication efficacy.

Increasing adoption of multiple assays

There is an increased usage of multiplex assays in companion diagnostics, as well as their advantages over singleplex & classical assays is the result of the growing prevalence of chronic diseases. The advantage of multiplex assays over singleplex tests, which includes lower reaction tie, chemicals, and analyte concentration, allows for faster assay results and the handling of unusual samples (low concentration sample). The high frequency of infectious and chronic diseases creates greater market potential through increasing demand for multiplex assays.

Market Restraining Factors;

Rising equipment costs and stringent regulations and standards

Multiplex assays comprise the potential to bring a new evolution across the healthcare industry and can play a major role in the developments and enhancements in medications that are being utilized in the treatment of numerous diseases and disorders such as cancer and neurological diseases. However, the equipment that is employed in the utilization of multiplex assays is very costly. Due to the higher cost of the equipment, the researchers or healthcare institutes that comprise lesser financial power would find it difficult to purchase and employ these products.

Product Outlook

Based on the Product, the Multiplex Assay Market is segregated into Reagents & Consumables, Instruments & Accessories, and Software & Services. In 2020, the Instruments & Accessories segment procured the maximum revenue share of the multiplex assays market. The industry standard multiplexing instruments and accessories are capable of performing multiple distinct tests in a single reaction volume. For instance, the flow cytometry-based equipment is capable of producing quick and cost-effective findings. These factors are majorly driving the growth of this segment.

Type Outlook

Based on the Type, the Multiplex Assay Market is segmented into Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assay, and Other multiplex Assays. In 2020, the Nucleic Acid-Based Multiplex Assay segment acquired a substantial revenue share of the multiplex assays market. It is owing to the significant features of the nucleic acid-based multiplex assays. Nucleic acid-based approaches are generally precise, and they may be used for a wide range of microorganisms. Because each test is often exclusive to an individual organism, the physician must be aware of the diagnostic options and make appropriate test requests.

End User Outlook

Based on the End-user, the Multiplex Assay Market is categorized into Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceutical & Biotechnology Companies. In 2020, the research institutes garnered a significant revenue share in the multiplex assays market. Multiplex assay methods are widely utilized in research and development operations. The rising utilization of the multiplex assays across research institutes is owing to the fact that multiplex assays provide convenience and faster results when running experiments.

Application Outlook

Based on the Application, the Multiplex Assay Market is divided into Clinical Diagnostics, Research & Development, and Companion Diagnostics. In 2020, the companion diagnostics segment procured the second-largest revenue share of the multiplex assays market. The growth of this segment is attributed to the fact that the test facilitates a practitioner to determine if the benefits of a drug combination can cause any potentially critical side effects to patients or not. Moreover, companion diagnostics tests allow healthcare practitioners to determine the efficiency of the personalized combination.

Regional Outlook

Based on the Region, the Multiplex Assay Market is analyzed across North America, Europe, APAC, and LAMEA. In 2020, North America emerged as the leading region in the multiplex assays market with the largest revenue share. The increased growth of the segment is attributed to the rise in the number of research institutes. Due to the increasing interest of North American researchers toward discovering more potentials of these immunoassays for making treatment of various diseases and disorders more efficient.

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Thermo Fisher Scientific, Inc. and Bio-Rad Laboratories, Inc. are the forerunners in the Multiplex Assay Market. Companies such as Becton, Dickinson and Company, Seegene, Inc. and DiaSorin S.p.A. (Luminex Corporation) are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Seegene, Inc., Randox Laboratories Limited, Illumina, Inc., Qiagen N.V., DiaSorin S.p.A. (Luminex Corporation), Abcam plc, and Meso Scale Diagnostics LLC.

Recent Strategies Deployed in Multiplex Assay Market

Partnerships, Collaborations and Agreements:

Oct-2021: Becton, Dickinson, and Company partnered with the Biomedical Advanced Research and Development Authority, a member of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness and Response. This partnership aimed to encourage the development of a range of COVID-19 combination diagnostic tests for core laboratories, at the point of care, and hospitals.

Jun-2021: Bio-Rad Laboratories entered into a partnership with Seegene, a leading vendor in multiplex molecular diagnostics. Through this partnership, the companies would emphasize bringing developments across clinics as well as commercializing infectious disease molecular diagnostic products. Under this partnership, Seegene assays provide multiplex concurrent PCR detection and differentiation with enhanced sensitivity and specificity of up to seven targets in one reaction. Moreover, the assays provide outcomes in an estimate of four hours.

May-2021: Qiagen joined hands with Mirati Therapeutics, a clinical-stage biotechnology company. The collaboration aimed to continue the development of KRAS companion diagnostic based on tissue in order to detect cancer with KRASG12C mutation in patients to provide a more efficient diagnosis with adagrasib.

Apr-2021: DiaSorin partnered with QIAGEN, a German provider of sample and assay technologies for molecular diagnostics. Following this partnership, the companies launched LIAISON LymeDetect assay for commercial usage under the CE mark. In addition, the new assay would facilitate the detection of early Lyme Borreliosis infection on LIAISON analyzer systems.

Aug-2020: Thermo Fisher's transplant diagnostic business came into collaboration with histocompatibility, infectious disease, and nephrology laboratories at Emory University, Stanford University, University of Cincinnati, and the University Health Network in Toronto. With this collaboration, the companies aimed to unveil the LABScreen COVID Plus Assay. The assay utilizes the Luminex xMAP technology in order to identify various different antibodies and fragments intending to make it more specific and reduce the opportunities of incorrect results.

Dec-2019: Illumina came into a partnership with ArcherDX, a growth-stage molecular diagnostics company. The companies aimed to develop in-vitro diagnostic tests for Archer's offerings of companion diagnostics-based next-generation sequencing. In addition, ArcherDX's IVD tests would run on NextSeq 550Dx System of Illumina. Moreover, ArcherDX would get mandatory regulator approvals for every IVD kit and their subsequent commercialization.

May-2017: Thermo Fisher Scientific partnered with Seegene, a leading vendor in multiplex molecular diagnostics technologies and assays. Under this partnership, the companies would focus on obtaining the approval of the US FDA for the AllplexTM range of Seegene while Thermo Fisher would work on gaining the approval for running AllplexTM on its QuantStudio, 5 Real-Time PCR System. In addition, the integration of these products would unlock a new standard of innovation across the industry in order to enable a comprehensive MDx solution.

Product Launches and Product Expansions:

Dec-2021: Becton, Dickinson, and Company introduced some enhancements in BD COR System with the addition of a new MX instrument. This product would offer high-throughput molecular testing of contagious diseases. Additionally, the new enhancement is CE marked to the IVD directive 98/79/EC. Moreover, the new instrument completed BD COR System, which comprises a PX instrument with the ability to deliver diagnostic samples by automating relevant pre-analytical processing steps, and a GX instrument which utilizes the BD Onclarity HPV Assay along with tended genotyping to screen for HPV infections.

Apr-2020: Bio-Rad Laboratories launched a blood-based immunoassay kit. The new product would facilitate the identification of antibodies to the coronavirus SARS-CoV-2 virus that causes COVID-19. In addition, leveraging serology tests in order to enhance the diagnosis of the COVID-19 along with screening populations can offer a well-detailed understanding of infection rates and immunity.

Approvals and Trials:

Nov-2021: DiaSorin along with QIAGEN received the approval for the LIAISON QuantiFERON, TB Gold Plus assay, from the US, FDA. The new product would be used on LIAISON XS, an automated platform of DiaSorin. In addition, the approval expands the accessibility of the customers across the US to automation solutions in order to process QIAGEN's best-in-class blood-based test for latent tuberculosis detection and facilitate the transformation from the conventional tuberculin skin tests.

Sep-2021: DiaSorin received approval for its Simplexa, a COVID-19 & Flu A/B Direct kit. This kit would enable the user an in vitro qualitative detection and differentiation of nucleic acids from critical acute respiratory syndrome coronavirus 2 along with influenza A virus as well as influenza B virus from the same sample of the patient. Moreover, this assay would be utilized on LIAISON MDX and can be directly conducted through nasopharyngeal swabs, eliminating the requirement for off-board extraction.

Jul-2021: Seegene received a CE-IVD mark for its Allplex SARS-CoV-2 Variants II Assay. This product range would detect major genetic mutations of SARS-CoV-2 variants including W152C, K417N, L452R, and K417T. Moreover, the variants diagnostic kit comprises the ability to detect a total of six COVID-19 variants that are apparently originated from India through a single sample viz. Delta Plus, Kappa, Gamma, Delta, Epsilon, and Beta

Feb-2020: Seegene received Korea Ministry of Food and Drug Safety approval for its Allplex 2019-nCoV Assay, a Real-time PCR assay for Emergency Use. Following this approval, the company would provide assays in Korea as well as all over the world.

Jun-2017: Bio-Rad Laboratories received the US FDA approval for its BioPlex 2200 Syphilis Total and RPR assay. The new product aimed to treat syphilis infection and comprise a fully automated Treponemal/non-Treponemal dual assay that identifies Treponema pallidum (T. Pallidum) and reagin antibodies at the same time to allow more efficient diagnosis and monitoring.

Geographical Expansions:

Jan-2021: Seegene expanded its geographical footprint in Latin America. Through this expansion, the company would enter the region with an increased focus on its multiplex assay product.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Reagents & Consumables
  • Instruments & Accessories
  • Software & Services

By Type

  • Protein Based Multiplex Assays
  • Nucleic Acid-Based Multiplex Assay
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Clinical Laboratories
  • Hospitals

By Application

  • Research & Development
  • Clinical Diagnostics
  • Companion Diagnostics

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Seegene, Inc.
  • Randox Laboratories Limited
  • Illumina, Inc.
  • Qiagen N.V.
  • DiaSorin S.p.A. (Luminex Corporation)
  • Abcam plc
  • Meso Scale Diagnostics LLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Multiplex Assay Market, by Product
    • 1.4.2 Global Multiplex Assay Market, by Type
    • 1.4.3 Global Multiplex Assay Market, by End User
    • 1.4.4 Global Multiplex Assay Market, by Application
    • 1.4.5 Global Multiplex Assay Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Approvals and Trials
    • 3.2.4 Geographical Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, May - 2021, Oct) Leading Players

Chapter 4. Global Multiplex Assay Market by Product

  • 4.1 Global Reagents & Consumables Market by Region
  • 4.2 Global Instruments & Accessories Market by Region
  • 4.3 Global Software & Services Market by Region

Chapter 5. Global Multiplex Assay Market by Type

  • 5.1 Global Protein Based Multiplex Assays Market by Region
  • 5.2 Global Nucleic Acid-Based Multiplex Assay Market by Region
  • 5.3 Global Others Market by Region

Chapter 6. Global Multiplex Assay Market by End User

  • 6.1 Global Pharmaceutical & Biotechnology Companies Market by Region
  • 6.2 Global Research Institutes Market by Region
  • 6.3 Global Clinical Laboratories Market by Region
  • 6.4 Global Hospitals Market by Region

Chapter 7. Global Multiplex Assay Market by Application

  • 7.1 Global Research & Development Market by Region
  • 7.2 Global Clinical Diagnostics Market by Region
  • 7.3 Global Companion Diagnostics Market by Region

Chapter 8. Global Multiplex Assay Market by Region

  • 8.1 North America Multiplex Assay Market
    • 8.1.1 North America Multiplex Assay Market by Product
      • 8.1.1.1 North America Reagents & Consumables Market by Country
      • 8.1.1.2 North America Instruments & Accessories Market by Country
      • 8.1.1.3 North America Software & Services Market by Country
    • 8.1.2 North America Multiplex Assay Market by Type
      • 8.1.2.1 North America Protein Based Multiplex Assays Market by Country
      • 8.1.2.2 North America Nucleic Acid-Based Multiplex Assay Market by Country
      • 8.1.2.3 North America Others Market by Country
    • 8.1.3 North America Multiplex Assay Market by End User
      • 8.1.3.1 North America Pharmaceutical & Biotechnology Companies Market by Country
      • 8.1.3.2 North America Research Institutes Market by Country
      • 8.1.3.3 North America Clinical Laboratories Market by Country
      • 8.1.3.4 North America Hospitals Market by Country
    • 8.1.4 North America Multiplex Assay Market by Application
      • 8.1.4.1 North America Research & Development Market by Country
      • 8.1.4.2 North America Clinical Diagnostics Market by Country
      • 8.1.4.3 North America Companion Diagnostics Market by Country
    • 8.1.5 North America Multiplex Assay Market by Country
      • 8.1.5.1 US Multiplex Assay Market
        • 8.1.5.1.1 US Multiplex Assay Market by Product
        • 8.1.5.1.2 US Multiplex Assay Market by Type
        • 8.1.5.1.3 US Multiplex Assay Market by End User
        • 8.1.5.1.4 US Multiplex Assay Market by Application
      • 8.1.5.2 Canada Multiplex Assay Market
        • 8.1.5.2.1 Canada Multiplex Assay Market by Product
        • 8.1.5.2.2 Canada Multiplex Assay Market by Type
        • 8.1.5.2.3 Canada Multiplex Assay Market by End User
        • 8.1.5.2.4 Canada Multiplex Assay Market by Application
      • 8.1.5.3 Mexico Multiplex Assay Market
        • 8.1.5.3.1 Mexico Multiplex Assay Market by Product
        • 8.1.5.3.2 Mexico Multiplex Assay Market by Type
        • 8.1.5.3.3 Mexico Multiplex Assay Market by End User
        • 8.1.5.3.4 Mexico Multiplex Assay Market by Application
      • 8.1.5.4 Rest of North America Multiplex Assay Market
        • 8.1.5.4.1 Rest of North America Multiplex Assay Market by Product
        • 8.1.5.4.2 Rest of North America Multiplex Assay Market by Type
        • 8.1.5.4.3 Rest of North America Multiplex Assay Market by End User
        • 8.1.5.4.4 Rest of North America Multiplex Assay Market by Application
  • 8.2 Europe Multiplex Assay Market
    • 8.2.1 Europe Multiplex Assay Market by Product
      • 8.2.1.1 Europe Reagents & Consumables Market by Country
      • 8.2.1.2 Europe Instruments & Accessories Market by Country
      • 8.2.1.3 Europe Software & Services Market by Country
    • 8.2.2 Europe Multiplex Assay Market by Type
      • 8.2.2.1 Europe Protein Based Multiplex Assays Market by Country
      • 8.2.2.2 Europe Nucleic Acid-Based Multiplex Assay Market by Country
      • 8.2.2.3 Europe Others Market by Country
    • 8.2.3 Europe Multiplex Assay Market by End User
      • 8.2.3.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
      • 8.2.3.2 Europe Research Institutes Market by Country
      • 8.2.3.3 Europe Clinical Laboratories Market by Country
      • 8.2.3.4 Europe Hospitals Market by Country
    • 8.2.4 Europe Multiplex Assay Market by Application
      • 8.2.4.1 Europe Research & Development Market by Country
      • 8.2.4.2 Europe Clinical Diagnostics Market by Country
      • 8.2.4.3 Europe Companion Diagnostics Market by Country
    • 8.2.5 Europe Multiplex Assay Market by Country
      • 8.2.5.1 Germany Multiplex Assay Market
        • 8.2.5.1.1 Germany Multiplex Assay Market by Product
        • 8.2.5.1.2 Germany Multiplex Assay Market by Type
        • 8.2.5.1.3 Germany Multiplex Assay Market by End User
        • 8.2.5.1.4 Germany Multiplex Assay Market by Application
      • 8.2.5.2 UK Multiplex Assay Market
        • 8.2.5.2.1 UK Multiplex Assay Market by Product
        • 8.2.5.2.2 UK Multiplex Assay Market by Type
        • 8.2.5.2.3 UK Multiplex Assay Market by End User
        • 8.2.5.2.4 UK Multiplex Assay Market by Application
      • 8.2.5.3 France Multiplex Assay Market
        • 8.2.5.3.1 France Multiplex Assay Market by Product
        • 8.2.5.3.2 France Multiplex Assay Market by Type
        • 8.2.5.3.3 France Multiplex Assay Market by End User
        • 8.2.5.3.4 France Multiplex Assay Market by Application
      • 8.2.5.4 Russia Multiplex Assay Market
        • 8.2.5.4.1 Russia Multiplex Assay Market by Product
        • 8.2.5.4.2 Russia Multiplex Assay Market by Type
        • 8.2.5.4.3 Russia Multiplex Assay Market by End User
        • 8.2.5.4.4 Russia Multiplex Assay Market by Application
      • 8.2.5.5 Spain Multiplex Assay Market
        • 8.2.5.5.1 Spain Multiplex Assay Market by Product
        • 8.2.5.5.2 Spain Multiplex Assay Market by Type
        • 8.2.5.5.3 Spain Multiplex Assay Market by End User
        • 8.2.5.5.4 Spain Multiplex Assay Market by Application
      • 8.2.5.6 Italy Multiplex Assay Market
        • 8.2.5.6.1 Italy Multiplex Assay Market by Product
        • 8.2.5.6.2 Italy Multiplex Assay Market by Type
        • 8.2.5.6.3 Italy Multiplex Assay Market by End User
        • 8.2.5.6.4 Italy Multiplex Assay Market by Application
      • 8.2.5.7 Rest of Europe Multiplex Assay Market
        • 8.2.5.7.1 Rest of Europe Multiplex Assay Market by Product
        • 8.2.5.7.2 Rest of Europe Multiplex Assay Market by Type
        • 8.2.5.7.3 Rest of Europe Multiplex Assay Market by End User
        • 8.2.5.7.4 Rest of Europe Multiplex Assay Market by Application
  • 8.3 Asia Pacific Multiplex Assay Market
    • 8.3.1 Asia Pacific Multiplex Assay Market by Product
      • 8.3.1.1 Asia Pacific Reagents & Consumables Market by Country
      • 8.3.1.2 Asia Pacific Instruments & Accessories Market by Country
      • 8.3.1.3 Asia Pacific Software & Services Market by Country
    • 8.3.2 Asia Pacific Multiplex Assay Market by Type
      • 8.3.2.1 Asia Pacific Protein Based Multiplex Assays Market by Country
      • 8.3.2.2 Asia Pacific Nucleic Acid-Based Multiplex Assay Market by Country
      • 8.3.2.3 Asia Pacific Others Market by Country
    • 8.3.3 Asia Pacific Multiplex Assay Market by End User
      • 8.3.3.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
      • 8.3.3.2 Asia Pacific Research Institutes Market by Country
      • 8.3.3.3 Asia Pacific Clinical Laboratories Market by Country
      • 8.3.3.4 Asia Pacific Hospitals Market by Country
    • 8.3.4 Asia Pacific Multiplex Assay Market by Application
      • 8.3.4.1 Asia Pacific Research & Development Market by Country
      • 8.3.4.2 Asia Pacific Clinical Diagnostics Market by Country
      • 8.3.4.3 Asia Pacific Companion Diagnostics Market by Country
    • 8.3.5 Asia Pacific Multiplex Assay Market by Country
      • 8.3.5.1 China Multiplex Assay Market
        • 8.3.5.1.1 China Multiplex Assay Market by Product
        • 8.3.5.1.2 China Multiplex Assay Market by Type
        • 8.3.5.1.3 China Multiplex Assay Market by End User
        • 8.3.5.1.4 China Multiplex Assay Market by Application
      • 8.3.5.2 Japan Multiplex Assay Market
        • 8.3.5.2.1 Japan Multiplex Assay Market by Product
        • 8.3.5.2.2 Japan Multiplex Assay Market by Type
        • 8.3.5.2.3 Japan Multiplex Assay Market by End User
        • 8.3.5.2.4 Japan Multiplex Assay Market by Application
      • 8.3.5.3 India Multiplex Assay Market
        • 8.3.5.3.1 India Multiplex Assay Market by Product
        • 8.3.5.3.2 India Multiplex Assay Market by Type
        • 8.3.5.3.3 India Multiplex Assay Market by End User
        • 8.3.5.3.4 India Multiplex Assay Market by Application
      • 8.3.5.4 South Korea Multiplex Assay Market
        • 8.3.5.4.1 South Korea Multiplex Assay Market by Product
        • 8.3.5.4.2 South Korea Multiplex Assay Market by Type
        • 8.3.5.4.3 South Korea Multiplex Assay Market by End User
        • 8.3.5.4.4 South Korea Multiplex Assay Market by Application
      • 8.3.5.5 Singapore Multiplex Assay Market
        • 8.3.5.5.1 Singapore Multiplex Assay Market by Product
        • 8.3.5.5.2 Singapore Multiplex Assay Market by Type
        • 8.3.5.5.3 Singapore Multiplex Assay Market by End User
        • 8.3.5.5.4 Singapore Multiplex Assay Market by Application
      • 8.3.5.6 Malaysia Multiplex Assay Market
        • 8.3.5.6.1 Malaysia Multiplex Assay Market by Product
        • 8.3.5.6.2 Malaysia Multiplex Assay Market by Type
        • 8.3.5.6.3 Malaysia Multiplex Assay Market by End User
        • 8.3.5.6.4 Malaysia Multiplex Assay Market by Application
      • 8.3.5.7 Rest of Asia Pacific Multiplex Assay Market
        • 8.3.5.7.1 Rest of Asia Pacific Multiplex Assay Market by Product
        • 8.3.5.7.2 Rest of Asia Pacific Multiplex Assay Market by Type
        • 8.3.5.7.3 Rest of Asia Pacific Multiplex Assay Market by End User
        • 8.3.5.7.4 Rest of Asia Pacific Multiplex Assay Market by Application
  • 8.4 LAMEA Multiplex Assay Market
    • 8.4.1 LAMEA Multiplex Assay Market by Product
      • 8.4.1.1 LAMEA Reagents & Consumables Market by Country
      • 8.4.1.2 LAMEA Instruments & Accessories Market by Country
      • 8.4.1.3 LAMEA Software & Services Market by Country
    • 8.4.2 LAMEA Multiplex Assay Market by Type
      • 8.4.2.1 LAMEA Protein Based Multiplex Assays Market by Country
      • 8.4.2.2 LAMEA Nucleic Acid-Based Multiplex Assay Market by Country
      • 8.4.2.3 LAMEA Others Market by Country
    • 8.4.3 LAMEA Multiplex Assay Market by End User
      • 8.4.3.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
      • 8.4.3.2 LAMEA Research Institutes Market by Country
      • 8.4.3.3 LAMEA Clinical Laboratories Market by Country
      • 8.4.3.4 LAMEA Hospitals Market by Country
    • 8.4.4 LAMEA Multiplex Assay Market by Application
      • 8.4.4.1 LAMEA Research & Development Market by Country
      • 8.4.4.2 LAMEA Clinical Diagnostics Market by Country
      • 8.4.4.3 LAMEA Companion Diagnostics Market by Country
    • 8.4.5 LAMEA Multiplex Assay Market by Country
      • 8.4.5.1 Brazil Multiplex Assay Market
        • 8.4.5.1.1 Brazil Multiplex Assay Market by Product
        • 8.4.5.1.2 Brazil Multiplex Assay Market by Type
        • 8.4.5.1.3 Brazil Multiplex Assay Market by End User
        • 8.4.5.1.4 Brazil Multiplex Assay Market by Application
      • 8.4.5.2 Argentina Multiplex Assay Market
        • 8.4.5.2.1 Argentina Multiplex Assay Market by Product
        • 8.4.5.2.2 Argentina Multiplex Assay Market by Type
        • 8.4.5.2.3 Argentina Multiplex Assay Market by End User
        • 8.4.5.2.4 Argentina Multiplex Assay Market by Application
      • 8.4.5.3 UAE Multiplex Assay Market
        • 8.4.5.3.1 UAE Multiplex Assay Market by Product
        • 8.4.5.3.2 UAE Multiplex Assay Market by Type
        • 8.4.5.3.3 UAE Multiplex Assay Market by End User
        • 8.4.5.3.4 UAE Multiplex Assay Market by Application
      • 8.4.5.4 Saudi Arabia Multiplex Assay Market
        • 8.4.5.4.1 Saudi Arabia Multiplex Assay Market by Product
        • 8.4.5.4.2 Saudi Arabia Multiplex Assay Market by Type
        • 8.4.5.4.3 Saudi Arabia Multiplex Assay Market by End User
        • 8.4.5.4.4 Saudi Arabia Multiplex Assay Market by Application
      • 8.4.5.5 South Africa Multiplex Assay Market
        • 8.4.5.5.1 South Africa Multiplex Assay Market by Product
        • 8.4.5.5.2 South Africa Multiplex Assay Market by Type
        • 8.4.5.5.3 South Africa Multiplex Assay Market by End User
        • 8.4.5.5.4 South Africa Multiplex Assay Market by Application
      • 8.4.5.6 Nigeria Multiplex Assay Market
        • 8.4.5.6.1 Nigeria Multiplex Assay Market by Product
        • 8.4.5.6.2 Nigeria Multiplex Assay Market by Type
        • 8.4.5.6.3 Nigeria Multiplex Assay Market by End User
        • 8.4.5.6.4 Nigeria Multiplex Assay Market by Application
      • 8.4.5.7 Rest of LAMEA Multiplex Assay Market
        • 8.4.5.7.1 Rest of LAMEA Multiplex Assay Market by Product
        • 8.4.5.7.2 Rest of LAMEA Multiplex Assay Market by Type
        • 8.4.5.7.3 Rest of LAMEA Multiplex Assay Market by End User
        • 8.4.5.7.4 Rest of LAMEA Multiplex Assay Market by Application

Chapter 9. Company Profiles

  • 9.1 Thermo Fisher Scientific, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
    • 9.1.6 SWOT Analysis
  • 9.2 Bio-Rad laboratories, Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
      • 9.2.5.3 Approvals and Trials:
  • 9.3 Becton, Dickinson and Company
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
      • 9.3.5.2 Product Launches and Product Expansions:
  • 9.4 Seegene, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Research & Development Expense
    • 9.4.4 Recent strategies and developments:
      • 9.4.4.1 Approvals and Trials:
      • 9.4.4.2 Geographical Expansions:
  • 9.5 Randox Laboratories Limited
    • 9.5.1 Company Overview
  • 9.6 Illumina, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
  • 9.7 Qiagen N.V.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Regional Analysis
    • 9.7.4 Research & Development Expense
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Partnerships, Collaborations, and Agreements:
  • 9.8 DiaSorin S.p.A. (Luminex Corporation)
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Partnerships, Collaborations, and Agreements:
      • 9.8.5.2 Approvals and Trials:
  • 9.9 Abcam plc
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expense
  • 9.10. Meso Scale Diagnostics LLC
    • 9.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 2 Global Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Multiplex Assay Market
  • TABLE 4 Product Launches And Product Expansions- Multiplex Assay Market
  • TABLE 5 Approvals and trials- Multiplex Assay Market
  • TABLE 6 Geographical Expansions- Multiplex Assay Market
  • TABLE 7 Global Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 8 Global Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 9 Global Reagents & Consumables Market by Region, 2017 - 2020, USD Million
  • TABLE 10 Global Reagents & Consumables Market by Region, 2021 - 2027, USD Million
  • TABLE 11 Global Instruments & Accessories Market by Region, 2017 - 2020, USD Million
  • TABLE 12 Global Instruments & Accessories Market by Region, 2021 - 2027, USD Million
  • TABLE 13 Global Software & Services Market by Region, 2017 - 2020, USD Million
  • TABLE 14 Global Software & Services Market by Region, 2021 - 2027, USD Million
  • TABLE 15 Global Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 16 Global Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 17 Global Protein Based Multiplex Assays Market by Region, 2017 - 2020, USD Million
  • TABLE 18 Global Protein Based Multiplex Assays Market by Region, 2021 - 2027, USD Million
  • TABLE 19 Global Nucleic Acid-Based Multiplex Assay Market by Region, 2017 - 2020, USD Million
  • TABLE 20 Global Nucleic Acid-Based Multiplex Assay Market by Region, 2021 - 2027, USD Million
  • TABLE 21 Global Others Market by Region, 2017 - 2020, USD Million
  • TABLE 22 Global Others Market by Region, 2021 - 2027, USD Million
  • TABLE 23 Global Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 24 Global Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 25 Global Pharmaceutical & Biotechnology Companies Market by Region, 2017 - 2020, USD Million
  • TABLE 26 Global Pharmaceutical & Biotechnology Companies Market by Region, 2021 - 2027, USD Million
  • TABLE 27 Global Research Institutes Market by Region, 2017 - 2020, USD Million
  • TABLE 28 Global Research Institutes Market by Region, 2021 - 2027, USD Million
  • TABLE 29 Global Clinical Laboratories Market by Region, 2017 - 2020, USD Million
  • TABLE 30 Global Clinical Laboratories Market by Region, 2021 - 2027, USD Million
  • TABLE 31 Global Hospitals Market by Region, 2017 - 2020, USD Million
  • TABLE 32 Global Hospitals Market by Region, 2021 - 2027, USD Million
  • TABLE 33 Global Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 34 Global Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 35 Global Research & Development Market by Region, 2017 - 2020, USD Million
  • TABLE 36 Global Research & Development Market by Region, 2021 - 2027, USD Million
  • TABLE 37 Global Clinical Diagnostics Market by Region, 2017 - 2020, USD Million
  • TABLE 38 Global Clinical Diagnostics Market by Region, 2021 - 2027, USD Million
  • TABLE 39 Global Companion Diagnostics Market by Region, 2017 - 2020, USD Million
  • TABLE 40 Global Companion Diagnostics Market by Region, 2021 - 2027, USD Million
  • TABLE 41 Global Multiplex Assay Market by Region, 2017 - 2020, USD Million
  • TABLE 42 Global Multiplex Assay Market by Region, 2021 - 2027, USD Million
  • TABLE 43 North America Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 44 North America Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 45 North America Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 46 North America Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 47 North America Reagents & Consumables Market by Country, 2017 - 2020, USD Million
  • TABLE 48 North America Reagents & Consumables Market by Country, 2021 - 2027, USD Million
  • TABLE 49 North America Instruments & Accessories Market by Country, 2017 - 2020, USD Million
  • TABLE 50 North America Instruments & Accessories Market by Country, 2021 - 2027, USD Million
  • TABLE 51 North America Software & Services Market by Country, 2017 - 2020, USD Million
  • TABLE 52 North America Software & Services Market by Country, 2021 - 2027, USD Million
  • TABLE 53 North America Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 54 North America Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 55 North America Protein Based Multiplex Assays Market by Country, 2017 - 2020, USD Million
  • TABLE 56 North America Protein Based Multiplex Assays Market by Country, 2021 - 2027, USD Million
  • TABLE 57 North America Nucleic Acid-Based Multiplex Assay Market by Country, 2017 - 2020, USD Million
  • TABLE 58 North America Nucleic Acid-Based Multiplex Assay Market by Country, 2021 - 2027, USD Million
  • TABLE 59 North America Others Market by Country, 2017 - 2020, USD Million
  • TABLE 60 North America Others Market by Country, 2021 - 2027, USD Million
  • TABLE 61 North America Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 62 North America Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 63 North America Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
  • TABLE 64 North America Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
  • TABLE 65 North America Research Institutes Market by Country, 2017 - 2020, USD Million
  • TABLE 66 North America Research Institutes Market by Country, 2021 - 2027, USD Million
  • TABLE 67 North America Clinical Laboratories Market by Country, 2017 - 2020, USD Million
  • TABLE 68 North America Clinical Laboratories Market by Country, 2021 - 2027, USD Million
  • TABLE 69 North America Hospitals Market by Country, 2017 - 2020, USD Million
  • TABLE 70 North America Hospitals Market by Country, 2021 - 2027, USD Million
  • TABLE 71 North America Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 72 North America Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 73 North America Research & Development Market by Country, 2017 - 2020, USD Million
  • TABLE 74 North America Research & Development Market by Country, 2021 - 2027, USD Million
  • TABLE 75 North America Clinical Diagnostics Market by Country, 2017 - 2020, USD Million
  • TABLE 76 North America Clinical Diagnostics Market by Country, 2021 - 2027, USD Million
  • TABLE 77 North America Companion Diagnostics Market by Country, 2017 - 2020, USD Million
  • TABLE 78 North America Companion Diagnostics Market by Country, 2021 - 2027, USD Million
  • TABLE 79 North America Multiplex Assay Market by Country, 2017 - 2020, USD Million
  • TABLE 80 North America Multiplex Assay Market by Country, 2021 - 2027, USD Million
  • TABLE 81 US Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 82 US Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 83 US Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 84 US Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 85 US Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 86 US Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 87 US Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 88 US Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 89 US Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 90 US Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 91 Canada Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 92 Canada Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 93 Canada Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 94 Canada Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 95 Canada Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 96 Canada Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 97 Canada Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 98 Canada Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 99 Canada Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 100 Canada Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 101 Mexico Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 102 Mexico Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 103 Mexico Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 104 Mexico Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 105 Mexico Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 106 Mexico Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 107 Mexico Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 108 Mexico Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 109 Mexico Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 110 Mexico Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 111 Rest of North America Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 112 Rest of North America Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 113 Rest of North America Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 114 Rest of North America Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 115 Rest of North America Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 116 Rest of North America Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 117 Rest of North America Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 118 Rest of North America Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 119 Rest of North America Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 120 Rest of North America Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 121 Europe Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 122 Europe Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 123 Europe Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 124 Europe Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 125 Europe Reagents & Consumables Market by Country, 2017 - 2020, USD Million
  • TABLE 126 Europe Reagents & Consumables Market by Country, 2021 - 2027, USD Million
  • TABLE 127 Europe Instruments & Accessories Market by Country, 2017 - 2020, USD Million
  • TABLE 128 Europe Instruments & Accessories Market by Country, 2021 - 2027, USD Million
  • TABLE 129 Europe Software & Services Market by Country, 2017 - 2020, USD Million
  • TABLE 130 Europe Software & Services Market by Country, 2021 - 2027, USD Million
  • TABLE 131 Europe Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 132 Europe Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 133 Europe Protein Based Multiplex Assays Market by Country, 2017 - 2020, USD Million
  • TABLE 134 Europe Protein Based Multiplex Assays Market by Country, 2021 - 2027, USD Million
  • TABLE 135 Europe Nucleic Acid-Based Multiplex Assay Market by Country, 2017 - 2020, USD Million
  • TABLE 136 Europe Nucleic Acid-Based Multiplex Assay Market by Country, 2021 - 2027, USD Million
  • TABLE 137 Europe Others Market by Country, 2017 - 2020, USD Million
  • TABLE 138 Europe Others Market by Country, 2021 - 2027, USD Million
  • TABLE 139 Europe Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 140 Europe Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 141 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
  • TABLE 142 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
  • TABLE 143 Europe Research Institutes Market by Country, 2017 - 2020, USD Million
  • TABLE 144 Europe Research Institutes Market by Country, 2021 - 2027, USD Million
  • TABLE 145 Europe Clinical Laboratories Market by Country, 2017 - 2020, USD Million
  • TABLE 146 Europe Clinical Laboratories Market by Country, 2021 - 2027, USD Million
  • TABLE 147 Europe Hospitals Market by Country, 2017 - 2020, USD Million
  • TABLE 148 Europe Hospitals Market by Country, 2021 - 2027, USD Million
  • TABLE 149 Europe Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 150 Europe Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 151 Europe Research & Development Market by Country, 2017 - 2020, USD Million
  • TABLE 152 Europe Research & Development Market by Country, 2021 - 2027, USD Million
  • TABLE 153 Europe Clinical Diagnostics Market by Country, 2017 - 2020, USD Million
  • TABLE 154 Europe Clinical Diagnostics Market by Country, 2021 - 2027, USD Million
  • TABLE 155 Europe Companion Diagnostics Market by Country, 2017 - 2020, USD Million
  • TABLE 156 Europe Companion Diagnostics Market by Country, 2021 - 2027, USD Million
  • TABLE 157 Europe Multiplex Assay Market by Country, 2017 - 2020, USD Million
  • TABLE 158 Europe Multiplex Assay Market by Country, 2021 - 2027, USD Million
  • TABLE 159 Germany Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 160 Germany Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 161 Germany Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 162 Germany Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 163 Germany Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 164 Germany Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 165 Germany Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 166 Germany Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 167 Germany Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 168 Germany Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 169 UK Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 170 UK Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 171 UK Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 172 UK Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 173 UK Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 174 UK Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 175 UK Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 176 UK Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 177 UK Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 178 UK Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 179 France Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 180 France Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 181 France Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 182 France Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 183 France Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 184 France Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 185 France Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 186 France Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 187 France Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 188 France Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 189 Russia Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 190 Russia Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 191 Russia Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 192 Russia Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 193 Russia Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 194 Russia Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 195 Russia Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 196 Russia Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 197 Russia Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 198 Russia Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 199 Spain Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 200 Spain Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 201 Spain Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 202 Spain Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 203 Spain Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 204 Spain Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 205 Spain Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 206 Spain Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 207 Spain Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 208 Spain Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 209 Italy Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 210 Italy Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 211 Italy Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 212 Italy Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 213 Italy Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 214 Italy Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 215 Italy Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 216 Italy Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 217 Italy Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 218 Italy Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 219 Rest of Europe Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 220 Rest of Europe Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 221 Rest of Europe Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 222 Rest of Europe Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 223 Rest of Europe Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 224 Rest of Europe Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 225 Rest of Europe Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 226 Rest of Europe Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 227 Rest of Europe Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 228 Rest of Europe Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 229 Asia Pacific Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 230 Asia Pacific Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 231 Asia Pacific Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 232 Asia Pacific Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 233 Asia Pacific Reagents & Consumables Market by Country, 2017 - 2020, USD Million
  • TABLE 234 Asia Pacific Reagents & Consumables Market by Country, 2021 - 2027, USD Million
  • TABLE 235 Asia Pacific Instruments & Accessories Market by Country, 2017 - 2020, USD Million
  • TABLE 236 Asia Pacific Instruments & Accessories Market by Country, 2021 - 2027, USD Million
  • TABLE 237 Asia Pacific Software & Services Market by Country, 2017 - 2020, USD Million
  • TABLE 238 Asia Pacific Software & Services Market by Country, 2021 - 2027, USD Million
  • TABLE 239 Asia Pacific Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 240 Asia Pacific Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 241 Asia Pacific Protein Based Multiplex Assays Market by Country, 2017 - 2020, USD Million
  • TABLE 242 Asia Pacific Protein Based Multiplex Assays Market by Country, 2021 - 2027, USD Million
  • TABLE 243 Asia Pacific Nucleic Acid-Based Multiplex Assay Market by Country, 2017 - 2020, USD Million
  • TABLE 244 Asia Pacific Nucleic Acid-Based Multiplex Assay Market by Country, 2021 - 2027, USD Million
  • TABLE 245 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
  • TABLE 246 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
  • TABLE 247 Asia Pacific Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 248 Asia Pacific Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 249 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
  • TABLE 250 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
  • TABLE 251 Asia Pacific Research Institutes Market by Country, 2017 - 2020, USD Million
  • TABLE 252 Asia Pacific Research Institutes Market by Country, 2021 - 2027, USD Million
  • TABLE 253 Asia Pacific Clinical Laboratories Market by Country, 2017 - 2020, USD Million
  • TABLE 254 Asia Pacific Clinical Laboratories Market by Country, 2021 - 2027, USD Million
  • TABLE 255 Asia Pacific Hospitals Market by Country, 2017 - 2020, USD Million
  • TABLE 256 Asia Pacific Hospitals Market by Country, 2021 - 2027, USD Million
  • TABLE 257 Asia Pacific Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 258 Asia Pacific Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 259 Asia Pacific Research & Development Market by Country, 2017 - 2020, USD Million
  • TABLE 260 Asia Pacific Research & Development Market by Country, 2021 - 2027, USD Million
  • TABLE 261 Asia Pacific Clinical Diagnostics Market by Country, 2017 - 2020, USD Million
  • TABLE 262 Asia Pacific Clinical Diagnostics Market by Country, 2021 - 2027, USD Million
  • TABLE 263 Asia Pacific Companion Diagnostics Market by Country, 2017 - 2020, USD Million
  • TABLE 264 Asia Pacific Companion Diagnostics Market by Country, 2021 - 2027, USD Million
  • TABLE 265 Asia Pacific Multiplex Assay Market by Country, 2017 - 2020, USD Million
  • TABLE 266 Asia Pacific Multiplex Assay Market by Country, 2021 - 2027, USD Million
  • TABLE 267 China Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 268 China Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 269 China Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 270 China Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 271 China Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 272 China Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 273 China Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 274 China Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 275 China Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 276 China Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 277 Japan Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 278 Japan Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 279 Japan Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 280 Japan Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 281 Japan Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 282 Japan Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 283 Japan Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 284 Japan Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 285 Japan Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 286 Japan Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 287 India Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 288 India Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 289 India Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 290 India Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 291 India Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 292 India Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 293 India Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 294 India Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 295 India Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 296 India Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 297 South Korea Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 298 South Korea Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 299 South Korea Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 300 South Korea Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 301 South Korea Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 302 South Korea Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 303 South Korea Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 304 South Korea Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 305 South Korea Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 306 South Korea Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 307 Singapore Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 308 Singapore Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 309 Singapore Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 310 Singapore Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 311 Singapore Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 312 Singapore Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 313 Singapore Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 314 Singapore Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 315 Singapore Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 316 Singapore Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 317 Malaysia Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 318 Malaysia Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 319 Malaysia Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 320 Malaysia Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 321 Malaysia Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 322 Malaysia Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 323 Malaysia Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 324 Malaysia Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 325 Malaysia Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 326 Malaysia Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 327 Rest of Asia Pacific Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 328 Rest of Asia Pacific Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 329 Rest of Asia Pacific Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 330 Rest of Asia Pacific Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 331 Rest of Asia Pacific Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 332 Rest of Asia Pacific Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 333 Rest of Asia Pacific Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 334 Rest of Asia Pacific Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 335 Rest of Asia Pacific Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 336 Rest of Asia Pacific Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 337 LAMEA Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 338 LAMEA Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 339 LAMEA Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 340 LAMEA Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 341 LAMEA Reagents & Consumables Market by Country, 2017 - 2020, USD Million
  • TABLE 342 LAMEA Reagents & Consumables Market by Country, 2021 - 2027, USD Million
  • TABLE 343 LAMEA Instruments & Accessories Market by Country, 2017 - 2020, USD Million
  • TABLE 344 LAMEA Instruments & Accessories Market by Country, 2021 - 2027, USD Million
  • TABLE 345 LAMEA Software & Services Market by Country, 2017 - 2020, USD Million
  • TABLE 346 LAMEA Software & Services Market by Country, 2021 - 2027, USD Million
  • TABLE 347 LAMEA Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 348 LAMEA Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 349 LAMEA Protein Based Multiplex Assays Market by Country, 2017 - 2020, USD Million
  • TABLE 350 LAMEA Protein Based Multiplex Assays Market by Country, 2021 - 2027, USD Million
  • TABLE 351 LAMEA Nucleic Acid-Based Multiplex Assay Market by Country, 2017 - 2020, USD Million
  • TABLE 352 LAMEA Nucleic Acid-Based Multiplex Assay Market by Country, 2021 - 2027, USD Million
  • TABLE 353 LAMEA Others Market by Country, 2017 - 2020, USD Million
  • TABLE 354 LAMEA Others Market by Country, 2021 - 2027, USD Million
  • TABLE 355 LAMEA Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 356 LAMEA Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 357 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
  • TABLE 358 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
  • TABLE 359 LAMEA Research Institutes Market by Country, 2017 - 2020, USD Million
  • TABLE 360 LAMEA Research Institutes Market by Country, 2021 - 2027, USD Million
  • TABLE 361 LAMEA Clinical Laboratories Market by Country, 2017 - 2020, USD Million
  • TABLE 362 LAMEA Clinical Laboratories Market by Country, 2021 - 2027, USD Million
  • TABLE 363 LAMEA Hospitals Market by Country, 2017 - 2020, USD Million
  • TABLE 364 LAMEA Hospitals Market by Country, 2021 - 2027, USD Million
  • TABLE 365 LAMEA Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 366 LAMEA Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 367 LAMEA Research & Development Market by Country, 2017 - 2020, USD Million
  • TABLE 368 LAMEA Research & Development Market by Country, 2021 - 2027, USD Million
  • TABLE 369 LAMEA Clinical Diagnostics Market by Country, 2017 - 2020, USD Million
  • TABLE 370 LAMEA Clinical Diagnostics Market by Country, 2021 - 2027, USD Million
  • TABLE 371 LAMEA Companion Diagnostics Market by Country, 2017 - 2020, USD Million
  • TABLE 372 LAMEA Companion Diagnostics Market by Country, 2021 - 2027, USD Million
  • TABLE 373 LAMEA Multiplex Assay Market by Country, 2017 - 2020, USD Million
  • TABLE 374 LAMEA Multiplex Assay Market by Country, 2021 - 2027, USD Million
  • TABLE 375 Brazil Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 376 Brazil Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 377 Brazil Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 378 Brazil Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 379 Brazil Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 380 Brazil Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 381 Brazil Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 382 Brazil Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 383 Brazil Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 384 Brazil Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 385 Argentina Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 386 Argentina Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 387 Argentina Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 388 Argentina Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 389 Argentina Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 390 Argentina Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 391 Argentina Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 392 Argentina Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 393 Argentina Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 394 Argentina Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 395 UAE Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 396 UAE Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 397 UAE Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 398 UAE Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 399 UAE Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 400 UAE Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 401 UAE Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 402 UAE Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 403 UAE Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 404 UAE Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 405 Saudi Arabia Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 406 Saudi Arabia Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 407 Saudi Arabia Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 408 Saudi Arabia Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 409 Saudi Arabia Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 410 Saudi Arabia Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 411 Saudi Arabia Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 412 Saudi Arabia Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 413 Saudi Arabia Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 414 Saudi Arabia Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 415 South Africa Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 416 South Africa Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 417 South Africa Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 418 South Africa Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 419 South Africa Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 420 South Africa Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 421 South Africa Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 422 South Africa Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 423 South Africa Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 424 South Africa Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 425 Nigeria Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 426 Nigeria Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 427 Nigeria Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 428 Nigeria Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 429 Nigeria Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 430 Nigeria Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 431 Nigeria Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 432 Nigeria Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 433 Nigeria Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 434 Nigeria Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 435 Rest of LAMEA Multiplex Assay Market, 2017 - 2020, USD Million
  • TABLE 436 Rest of LAMEA Multiplex Assay Market, 2021 - 2027, USD Million
  • TABLE 437 Rest of LAMEA Multiplex Assay Market by Product, 2017 - 2020, USD Million
  • TABLE 438 Rest of LAMEA Multiplex Assay Market by Product, 2021 - 2027, USD Million
  • TABLE 439 Rest of LAMEA Multiplex Assay Market by Type, 2017 - 2020, USD Million
  • TABLE 440 Rest of LAMEA Multiplex Assay Market by Type, 2021 - 2027, USD Million
  • TABLE 441 Rest of LAMEA Multiplex Assay Market by End User, 2017 - 2020, USD Million
  • TABLE 442 Rest of LAMEA Multiplex Assay Market by End User, 2021 - 2027, USD Million
  • TABLE 443 Rest of LAMEA Multiplex Assay Market by Application, 2017 - 2020, USD Million
  • TABLE 444 Rest of LAMEA Multiplex Assay Market by Application, 2021 - 2027, USD Million
  • TABLE 445 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 446 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 447 Key information - Becton, Dickinson and Company
  • TABLE 448 key information - Seegene, Inc.
  • TABLE 449 Key Information - randox laboratories limited
  • TABLE 450 key information - Illumina, Inc.
  • TABLE 451 Key Information -Qiagen N.V.
  • TABLE 452 Key Information - DiaSorin S.p.A.
  • TABLE 453 key information - Abcam plc
  • TABLE 454 Key Information - Meso Scale Diagnostics LLC

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
  • FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, may - 2021, oct) Leading Players
  • FIG 5 Swot analysis: thermo fisher scientific, inc.
  • FIG 6 Recent strategies and developments: Bio-Rad Laboratories, Inc.
  • FIG 7 Recent strategies and developments: Becton, Dickinson and Company
  • FIG 8 Recent strategies and developments: Seegene, Inc.